Brenntag Specialties and Zeochem expand collaboration for Pharma EMEA
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer
Approval based on results from TOPAZ-1 global Phase III trial and a Chinese patient
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
This collaboration underscores WOTR's unwavering commitment to strengthening rural communities against the unpredictable variations of climate change
The collaboration brings a seamless digital experience to more formulators worldwide
PhytoSquene now available for clinical and commercial use
This product will be manufactured at Lupin’s Pithampur facility in India
The newly developed adhesive is available in two different grades. Loctite WT 3001 and Loctite WT 3003 h
Subscribe To Our Newsletter & Stay Updated